Currently recruiting gastro-intestinal trials
Protocol: AMT-676-01 (PI: DR Warren Joubert) (NOT YET RECRUITING)
Protocol Title: First-in-Human, Phase 1 Study of AMT-676, an Anti CDH17 Antibody-Drug Conjugate, in Patients with Advanced Solid Tumors
Protocol: AMP945-PC-201 (PI: Dr Warren Joubert)
Protocol Title: A Phase 1b/2a, Multicentre, Open Label Study of the Pharmacokinetics, Safety and Efficacy of AMP945 in Combination with Nab-paclitaxel and Gemcitabine in Pancreatic Cancer Patients
Lay Title: AMP945 in Combination With Nab-paclitaxel and Gemcitabine for Treatment of Pancreatic Cancer
Click here for more information